The diabetes epidemic in the United States (US) has evolved considerably over the last quarter century. Though the evidence base for diabetes prevention and management has grown, major gaps persist: 1) The proportion of people with undiagnosed diabetes and prediabetes has not improved; 2) Engagement in prevention is exceedingly low; and 3) Young adults and disenfranchised populations with diabetes fare poorly in terms of control.
To address these trends in Georgia, where disparities in diabetes outcomes are particularly apparent, Emory University, the Georgia Institute of Technology, and Morehouse School of Medicine collaboratively established the Georgia Center for Diabetes Translation Research (GCDTR), funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK - P30DK111024) and inter‐institutional partners.
GCDTR is one of eight NIDDK-funded Centers for Diabetes Translation Research (CDTR). To learn more about CDTRs supporting and enhancing type 2 translation research, click here.